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Objectives. The clinical value of cine magnetic resonance
imaging (MRI) during dobutamine stress for detection of coronary
artery disease was evaluated in 45 patients with chest pain who
were admitted for coronary arterlography .
Background
. Development of stress-induced wall motion asyn-
ergy is considered an early and reliable sign of myocardial
ischemia preceding electrocardiographic (ECG) changes and an-
gina. As physical exercise during MRI is difficult because of
motion artifacts and space restriction, dobutamine infusion was
used to induce cardiovascular stress .
Methods. Clue MRI tomograms were obtained in six adjacent
short-axis planes. After baseline acquisition, dobutamine was
administered to a maximal dose of 20 pglkg per min. Both at rest
and during peak dobutamine stress, magnetic resonance images
were displayed in a cinematographic loop to assess regional wall
motion qualitatively . Results of dobutamine MRI were considered
positive for coronary artery disease if any new or worsening mail
motion abnormality developed. Immediately after MRI at peak
Exercise stress testing is commonly used to demonstrate
myocardial ischemia in patients with suspected coronary
artery disease. However, ST segment depression and angina
are rather late manifestations of myocardial ischemia . The
occurrence of wall motion abnormalities has been consid-
ered an early and sensitive marker of myocardial ischemia,
preceding the development of ST segment depression and
anginal symptoms (1-3) . Therefore, it is invaluable to de-
velop reliable imaging methods for assessing accurately
regional left ventricular function . Magnetic resonance imag-
ing (MRI) is a noninvasive tomographic technique that
provides a three-dimensional data set with high spatial
resolution, allowing assessment of left ventricular dimen-
sions independently of geometric assumptions (4,5) . Gradi-
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dobutamine infusion, dobutamine electrocardiography was per-
formed outside the magnetic environment . In addition, all patients
performed symptom-lih.ited exercise electrocardiography.
Results. Significant coronary artery disease (>50% diameter
stenosis) was present in 37 patients. During peak dobutamine
stress, wall motion asynergy developed or worsened in 30 tients,
yielding an overall sensitivity for detectioc of coronary artery
disease of 81% and a specificity of 100% . Corresponding data
were 51% and 63% for dobutamine electrocardiography and 70%
and 63% for exercise electrocardiography . The sensitivity of
dobutamine MRI for the detection of coronary artery disease in
patients wilts single-, double- and triple-vessel disease was 75%
(15 of 20 patients), 80% (8 of 10) and 100% (7 of 7), respectively .
Conclusion. Dob, .amine MRI is an accurate nonexercise-
dependent method for the assessment of myocardial ischemia in
patients with coronary artery disease.
(J Am Coil Cardiol 1993;22 :431-9)
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ent echo (cine) sequences provide improved temporal reso-
lution to identify end-diastole and end-systole in the
evaluation of ventricular function (6,7) . Accurate endocar-
dial border delineation is facilitated by the inherent contrast
between the moving blood pool and the relatively stationary
myocardial wall. The value of cine MRI in detecting abnor-
malities in regional (8) and global (9) left ventricular function
has been shown previously . Several studies (10-12) using
tine MRI have reported accurate measurements of left
ventricular volumes and ejection fraction that correlated
well with data obtained by cine ventriculography and two-
4imensional echocardiography . Space restriction and motion
artifacts preclude performance of physical exercise during
MRI. Consequently, alternatives to dynamic exercise
are
required in the assessment of coronary artery disease with
MRI (13) . It has been demonstrated experimentally (14) that
dobutamine is an effective pharmacologic stress agent to
induce wall motion abnormalities. Several studies (15-20)
have reported the accuracy of dobutamine stress in combi-
nation with two-dimensional echocardiography in detecting
coronary artery disease .
This study was designed to determine the accuracy of
dobutamine stress in conjunction with tine
MRI for the
diagnosis of coronary artery disease in patients admitted for
0735-10971931$600
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coronary angiography and the assessment of patient toler-
ance of this approach .
Methods
Study patients. We screened 50 consecutive patients who
were admitted for elective coronary arteriography for eval-
uation of suspected coronary artery disease . Patients with
atrial fibrillation, a pacemaker, claustrophobia, cerebral vas-
cular clips, heart failure, unstable angina, known ventricular
arrhythmias, hypertrophic cardiomyopathy, valvular heart
disease and uncontrolled hypertension were excluded . Two
patients were excluded because of unacceptable baseline
MRI tomograms. Three patients who demonstrated claustro-
phobia during baseline MRI acquisition did not receive
dobutamine infusion and were also excluded from the study .
The remaining 45 patients (36 men and 9 women [mean age
61 ± 9 years, range 43 to 74]) underwent dobutamine stress
MRI followed by dobutamine electrocardiography, coronary
arteriography and exercise stress testing in random order
within 2 weeks. All patients were in sinus rhythm and all had
a history of exertional chest pain . Eleven patients had a
history of previous myocardial infarction (postinfarction
time >6 months). Beta-adrenergic blocking agents were
discontinued 48 h before both dobutamine and exercise
stress tests . Nitrates and calcium antagonists were not taken
the day of the test. The study protocol was approved by the
hosp::al Ethics Committee on Human Research and in-
formed consent was obtained from each patient .
Cardiac catheterization . Coronary angiography and bi-
plaea tine ventriculography were performed according to
the Judkins technique. Multiple views of each coronary
artery were obtained . All angiograms were analyzed by two
independent observers who were unaware of the clinical
data. Coronary artery narrowings were expressed as percent
diameter stenosis. Significant coronary artery stenosis was
defined as >50% lumen narrowing of a major epicardial
coronary artery or major branch vessel .
Dobutantine stress protocol. Before the MRI procedure,
an intravenous cannula was inserted into the antecubital vein
of the right arm and flushed with heparin to prevent coagu-
lation
. Dobutamine was administered intravenously by an
IVAC syringe pump that was placed outside the magnetic
environment and connected by means of a long line with the
cannula, which was primed with dobutamine solution. After
the baseline magnetic resonance images were obtained,
dobutamine was infused at an initial rate of 5 pg/kg per min,
followed by an incremental regimen of 5 pg/kg per min every
2 min. The time to reach steady state at peak infusion rate
was 14 ± 2 min after the start of the infusion . Cine MRI was
performed at baseline and at the maximal infusion rate of
20 pg/kg per min. The dobutamine infusion was discontinued
when any of the following criteria for termination occurred :
1) significant side effects (chest pain, arrhythmia, dyspnea or
other intolerable symptoms)
; 2) systolic blood pressure
>220 mm Hg or a decrease >20 mm Hg ; 3) diastolic blood
Dobutamlne Infusion
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Figure 1. Time diagram of the dobutamine infusion protocol, base-
line and stress magnetic resonance imaging (MRI) protocol . Imme-
diately after stress MRI, an electrocardiogram (ECG) was taken
outside the magnetic environment .
pressure >110 mm Hg ; 4) achievement of the target heart
rate (85% of the age-predicted maximal heart rate) ; and 5)
maximal infusion rate of 20 µg/kg per min. Intravenous
metoprolol (1 mg/ml) was available to treat side effects .
Blood pressure was recorded by an automatic device
(Physio-Control) on the left arm every minute during infu-
sion.
Clue magnetic resonance imaging. Cine MRI was per-
formed at a magnetic field strength of 1 .5 tesla using a
Gyroscan superconducting magnet (Philips Medical Sys-
tems). The electrocardiographic (ECG) signal was recorded
simultaneously and transmitted by telemetry to a remote
receiver (Hewlett-Packard) to trigger the acquisition accord-
ing to the R wave . The shortest possible trigger delay was
8 ms after the R wave of the ECG. Images triggered by the
ECG were acquired in the true short-axis plane of the heart,
which was derived from coronal and sagittal scout views,
followed by double-oblique angulation . Cine MRI was per-
formed using a flow-compensated gradient echo sequence
(repetition time [TR] 30 ms, echo time [T E] 13 ms, excitation
angle 30). Six contiguous slices were taken with a thickness
of 10 mm, starting at the basal level, and each slice was
imaged separately . The acquisition matrix was 128 x 256 and
was interpolated to 256 x 256 for display purposes . The field
of view was 350 mm and four acquisitions were averaged to
improve signal to noise ratio. The number of sequential
frames per cardiac cycle corresponded to the number of 30°
pulses delivered within one RR interval . Accordingly, with a
heart rate of 60 beats/min, the RR interval was 1,000 ms and
composed of 30 time frames (RR interval/TR) because the
final 100 ms of the diastole could not be imaged . The imaging
time for one total baseline acquisition was 42 ± 4 min . The
increase in heart rate caused by dobutamine reduced the
imaging time during stress to 24 ± 6 min (Fig . 1) .
Electrocardiography during exercise stress and dobu-
tamine Infusion. Immediately after completion of the dobu-
tamine MRI protocol, the dobutamine infusion was contin-
ued and a 12-lead ECG was taken outside the magnetic
environment .
In addition, all patients performed a multistage upright
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Figure 2. Schematic representation of six adjacent short-axis levels
from base (top) to low left ventricular level (bottom) with regions of
coronary artery distribution ; I = septal ; 2 = anteroseptsl ; 3 =
anterior ; 4 = lateral ; 5 = posterolateral; 6 = posterior .
bicycle ergometer test with an initial load of 25 W and
increments of 25 W every 2 min . A 12-lead ECG and blood
pressure were recorded at baseline and thereafter every
2 min during exercise . Criteria for termination of the test
were severe angina, limiting dyspnea or fatigue, >20 mm Hg
decrease in systolic blood pressure, >2 mm ST segment shift
or arrhythmias (atrial fibrillation, atrial flutter or other forms
of supraventricular tachycardia and ventricular tachycar-
dia). Both exercise and dobutamine stress ECGs were con-
sidered positive for ischemia when > 1 mm of horizontal or
downsloping ST segment depression 80 ms after the J point
in any lead occurred during three consecutive beats .
Analysis of due magnetic resonance images. Magnetic
resonance tomograms were analyzed independently by two
observers who had no knowledge of the patient's history,
results of stress electrocardiography or coronary angiogra-
phy. Disagreement in interpretation was resolved by consen-
sus. Initially, at each level the short-axis images were
displayed in a cinematographic format to visualize the con-
traction pattern through the cardiac cycle . The images
obtained at 8 ms after the R wave on the ECG were
considered to represent end-diastole and the images with the
smallest lumen area gr the thickest wall, or both, were
considered to represent end-systole .
For purposes of wall motion analysis, short-axis images
were divided according to the vascular distribution of the
major epicardial coronary arteries (Fig . 2). The septal,
anteroseptal and anterior segments were considered specific
for the left anterior descending coronary artery distribution
and the lateral region for the left circumflex coronary artery
distribution, whereas the posterolateral and posterior areas
VAN RLJGGE ET AL.
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were regarded as the territory of the left circumflex or right
coronary artery depending on dominance of the right coro-
nary artery . Wall motion at rest was classified in each
segment as normal . hypokinetic, akinctic or dyskinetic using
criteria that rely on both inward endocardial wall motion and
systolic wall thickening . A normal response to dobutamine
infusion was defined as hyperdynamic motion, consisting of
increased inward endocardial motion with enhanced systolic
wall thickening. A response to dobutamine infusion was
considered positive for coronary artery disease when one of
the following criteria were met at any level : 1) in patients
without wall motion abnormalities at rest, development of
new wall motion asynergy at any region during dobutamine
stress; 2) in patients with wall motion abnormalities at rest,
stress-induced worsening of a wall motion abnormality at
rest, which was defined as wall motion deteriorating from
hypokinesia to akinesia or dyskinesia, spreading of a wall
motion abnormality at rest to a contiguous segment within
the distribution of the same coronary artery or development
of aiiy new wall motion abnormality in a region demonstrat-
ing normal baseline contraction .
Statistical analysis. Data are presented as mean value ± I
SD. The sensitivity, specificity and predictive accuracy for
dobutamine electrocardiography, dobutaminc MIDI and ex-
ercise electrocardiography, respectively, are estimated with
the associated 95% confidence intervals .
The hemodynamic alterations during dobutamine and
exercise stress were analyzed by two-way analysis of vari-
ance with repeated measures . Discrete variables were com-
pared by chi-square analysis. A p value < 0.05 was consid-
ered statistically significant .
Results
Cardiac catheterization. The artgtographic data are listed
in Table 1 . Eight patients had no coronary artery disease .
Significant coronary artery disease (>50% diameter steno-
sis) was present in 37 patients (82%) : 20 patients with
single-vessel, 10 with double-vessel and 7 with triple-vessel
disease. No patient had left main coronary artery disease .
Eleven patients demonstrated wall motion abnormalities at
rest during biplane ventriculography.
Ilemodynamic responses to dobutamine and exercise stress
(Tables 1 and 2)
. The responses of the hemodynantic vari-
ables to dobutamine infusion and exercise stress tecting are
presented in Table 2 . There were: no significant differences
between patients without or with coronary artery disease
with respect to heart rate, systolic blood pressure, diastolic
blood pressure and rate-press - : ;i, product for each of the
three conditions (rest, dobutamine stress, exercise stress
:
p > 0.09). Heart rate, systolic blood pressure and rate-
pressure product were significantly different among the three
conditions: heart rate, systolic blood pressure and rate-
pressure product increased significantly (p < 0 .001) in all
patients during bath exercise and dobutamine . Moreover,
during peak dobutarnine stress, the mean maximal heart rate
'The worst grade of wall motion asynergy is depicted . A = anterior,
Ak = akinesia: AS = anteroseptal ; CAD = coronary artery disease
; Dk
= dyskinesia
;
ECG = electrocardiogram : F = female; Hk = hypokinesia
; HR = heart rate (beats/min) ; L = lateral ; LAD
= left anterior descending coronary artery ; LCx =
left circumflex coronary artery ; M = male
; Max = maximal; MR[ = magnetic resonance imaging ; P = posterior
; PL = posterolateral ; Pt = patient ; RCA = right
coronary artery
; RPP
= rate-pressure prod""ct (mm Hg/min)
; S = septal ; SBP = systolic blood pressure (mm Hg) ; WMA = wall motion abnormality ; - _
negadvelabsent
; + = positive/present
.
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Table I
. Clinical Data and Results of Coronary Angiography, Exercise Electrocardiography, Dobutamine Electrocardiography and
Dobutamine Magnetic Resonance Imaging
Dobutamine MRI
Pt
Age (yr)l
	
Nu. and Type of
Rest Exercise
Dobutamine Max Max
Max
Wall Motion Abnormality
No. Gender
Diseased Vessels WMA
ECG ECG
HR SHP RPP +l- Site Type*
Patients Without CAD
I
601M 0
109 170 18,530
2 63/M U
+ 125 152 19,000
3 491M
0
+ 112 157
17,584
4 67/M
0
+
+ 124
175
21,700
5 531F 0
- 118 164 19,352
6 69/24 0
111 181 20,091
7
61/F 0
+ 116 164 19,024
8 56117
0
+ 96 179 17,184
Patients With CAD
9 65124 I LAD
107 162
17,334
l0 58/M I LAD
- I15 173 19.895 -
II 431M I LAD
+ 120
166 19,920
+
S Ak
12 721M I LAD
93 145 13.485 + SIAS Ak
13 651F I LAD
+ 142 144
20,449 +
S/AS Hk
14 791M I LAD + 121 174 21,054
+
S/AS
Ak
15 531M 1 LAD +
+
128
181 23,168
+ S Hk
16 66/M I LAD
+
1I6
169 19,604 + AS Ak
17 551F I LAD
+ + 112 182 20,394
18 52/M I LCx
+
+
105 198 20,790
+
IJPL Ak
19 75/M I LCx
+ +
128
137 17,536 +
PUP
Ak
20 52124 I LCx
+
111 183
20.313 + L Ak
21 721M
I LCx + + 107 167 17,869 + PLIP Hk
22 571M 1 LCx 120 158 18,960
23 44/24 1 LCx
+ +
118
159 18,762 + P
Hk
24 701M
I LCx
+ + 105 198 20,790
+
L Hk
25 74124
I LCx
+
114 138 15,732 + PUP Ak
26 SLIM 1 RCA + + 98 168 16,464
27 48/F I RCA
+ +
126 172 21,672 + P Hk
28 601M I RCA + +
120
158
18,960
+ P
Dk
29 64/M 2 LAD, LCx + + +
136 143 19.448
+
AIL Ak
30 64/24 2 LAD, LCx + + 125 142
17,750
+
PIS
ilk
31 631F 2 LAD, LCx 119 160 19,040 +
S
Hk
32 66124 2 LAD, LCx + +
125 179 22,375
+
AS/A/L Ak
33 511F 2
LAD, LCx
+
127 149 18,923
34 62/M 2 LAD, RCA +
107 204 21,828 + AS Hk
35 74/M 2 LAD, RCA + +
130 157 20,410
+
PIS Hk
36 67/M
2 LAD, RCA +
109
168
18,312 + P/S Ilk
37 74/F 2 LAD, RCA
+ 112 157 17,584 -
38 60/24 2 RCA, LCx + + +
120 207 24,840 + L/PLIP Ak
39 60/24 3 +
120 202 24,240
+
P/S/AS Hk
40 S7iM
3 + + +
103 196 20,188 + AS/AJL Ak
41 501M
3 + +
120 180 21 .600
+
A/LIP Hk
42 53/24 3 +
+ +
130
167
21,710
+
LIP/S Ak
43
66/24 3 +
I15 183 21,045 +
At/P Ak
44 59/24
3 + +
115 167 19,205
+
P/LIA Ak
45 621M 3
+ +
107 173 18,511 + P1S Dk
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Table 2. Mean Hemodynamic Alterations During Exercise and
Dobutamine Stress
$p <
.3.001 versus rest and exercise . t
p = NS versus rest and exercise.
Values are expressed as mean value ± SD .
(116 ± 10 vs. 133 ± 12 beatsimin, p < 0.001), maximal
systolic blood pressure (169 ± 18 vs. 188 ± 20 mm Hg, p <
0.001) and maximal rate-pressure product (19,613 ± 2,137
vs. 24,833 ± 3,648 mm hg/min, p < 0.001) were lower than
during exercise . Diastolic blood pressure did not change
significantly during dobutamine stress or exercise. Three
patients did not achieve I . heart rate >100 beats/min at peak
dobutamine stress .
Dobutamme magnetic resonance imaging (Tables I to 4).
The results of cine MRI imaging during dobutamine stress
arc presented in Table I . The MRI quality during dobu-
tamine stress was good in all 45 patients, allowing qualitative
wall motion analysis (F." . 3 and 4) . The normal response to
dobutamine stress was increased reward endocardial wall
motion with enhanced systolic wall thickening (hyperkine-
sia). Eleven patients demonstrated
wall motion abnormali-
ties at rest that either deteriorated further or spread to a
contiguous segment during peak dobutamine stress ; all had
documented myocardial infarction . Nineteen patients with-
out wall motion asynergy at rest developed new wall motion
abnormalities during dobutamine stress
indicating the pres-
ence of coronary artery disease . Thus, dobutamine MRI
results were positive in 30 of 37 patients with proved
coronary artery disease, yielding an
overall sensitivity of
81% (associated 95% confidence interval [CI] 65% to 92%)
(Table 3). The zest result was negative in all
patients without
coronary artery disease (specificity 100%, 95% CI 63% to
100%) and the predictive accuracy of the test was
84% (95%
Table 3. Sensitivity, Specificity and Predictive Accuracy of
Dobutamine Magnetic Resonance Imaging (MRI), rwbutamine
Electrocardiography and Exercise Electrocardiography for
Detection of Coronary Artery Disease
*p < O.Oi versus dobutamine electrocardiography .
t p = NS versus
dobutamine magnetic resonance imaging and dobutamine
electrocardio-
graphy. Data indicate number of patients and, in
parentheses, percent
sensitivity, specificity or accuracy .
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Table 4. Sensitivity of Dobutamine Stress Magnetic Resonance
Imaging (MRI), Dobutamine Electrocardiography and Exercise
Electrocardiography for Detecting One-, Two- and Three-Vessel
Coronary Artery Disease
435
Data indicate number of patients and, in parentheses, percent sensitivity .
Cl 71% to 94%) . The sensitivity for detecting coronary
artery disease in patients with single-vessel disease was 75%
(15 of 20 patients, 95% CI 51% to 91%), 80% (8 of 10, 95% CI
44% to %) for double-vessel disease and 100% (7 of 7, 95%
Cl 59% to 100%) for triple-vessel diseasr. (Table 4) .
Electrocardiographic responses to dobutamine and exercise
stress (Tables 3 and 4) . During peak dobutamine stress,
ischemic ST segment depression was induced in 19 patients
with coronary artery disease and three patients with normal
coronary arteries, yielding a sensitivity and specificity for
detection of coronary artery disease of 51% (95% Cl 34% to
68%) and 63% (95% CI 25% to 92%), respectively. The
sensitivity for detecting coronary artery disea in patients
with single-, double- and triple-vessel disease was 45% (95%
Figure 3 . Baseline (upper row) and dobutamine stress (lower row)
tine magnetic resonance imaging tomograms at end-diastole (left
ca uana) and end-systole (right column) in a patient with significant
right coronary artery stenosis . The
baseline contraction pattern is
normal with homogeneous systolic wall thickening (upper right
paiel), but at peak dobutamine stress the posterior wall fails to
demonstrate systolic wall thickening (lower right panel, arrow) .
Sensitivity Specificity Accuracy
Dobutamine MRI 30137 (8q" 8/8(100)
38145 (84)
Dobutamine electrocardiography 19137 (51) 518(63)
24145 (53)
Exercise electrocardiography 26137 (70)t 518(63)
31145 (69)
Rest Exercise
Dobutam;r.e^
(20Ing/k
:-~Aeoin)
Heart rate (beats/min) 72 ± 11 133 *_ 12 116 *_ hr
Systolic blood pressure
(mm Hg)
129 ±
21
188 ±
20
169 ± 18*
Rate-pressure product
(mm Hg/min)
9,288 ± 1,043 24,833 ± 3,648 19,613 ± 1,137*
Diastolic blood pressure
(mm Hg)
85
±
10 88
±
Il 84
± I3f
Diseased
Vessels
(no.)
S asitivity
Dobutamine
MRI
Dobutamine
Electrocardiography
Exercise
Electrocardiography
1 15120 (75)
9/20(45)
12120 (60)
2 8110 (80) 511000) 8/10(80)
3 7n (100) 5/7(71) 617(86)
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Figure 4. Baseline (upper raw) and dobutamine stress (tower row)
cine magnetic resonance imaging tomograms at end-diastole (left
column) and end-systole (right column) in a patient with significant
left anterior descending coronary artery stenosis . The baseline
contraction pattern is normal with homogeneous systolic wall thick-
ening (upper right panel), but at peak dobutamine stress the an-
teroseptal wall fails to demonstrate systolic wall thickening (tower
right panel, arrows) .
CI 23% to 69%),50%(95% CI 19% to 8l%) and 71% (95% CI
29% to 96%), respectively .
Exercise ECG demonstrated a sensitivity and specificity
for detecting coronary artery disease of 70% (95% CI 53% to
84%) and 63% (95% CI 25% to 92%), respectively . The
sensitivity for detecting single-, double- and triple-vessel
disease was 60% (95% CI 36% to 81%), 80% (95% CI 44% to
98%) and 86% (95% CI 42% to 100%), respectively .
Stile effects and tolerance to dobutamine stress. During
dobutamine infusion, all side effects were transient and
reversed rapidly after termination of the infusion. No patient
required administration of metoprolol . Chest pain developed
in 9 (20%) of 45 patients with dobutamine stress compared
with 20 (44%) of 45 patients during exercise stress testing
(p < 0.005). Dobutamine-induced chest pain was controlled
by reducing the infusion rate, and no patient needed admin-
istration of sublingual nitroglycerin . All patients with dobu-
tamine-induced chest pain had significant coronary artery
disease and demonstrated ischemic ST segment depression
during dobutamine electrocardiography immediately after
the cine MRI. Arrhythmias were seen in 6 (13%) of 45
patients, of whom 5 had frequent ventricular premature
complexes
. One patient demonstrated accelerated idioven-
tricular rhythm and this event was considered to be an
indication for premature termination of dobutamine infusion ;
thereafter the arrhythmia rapidly resolved . Thus, 35 patients
tolerated the peak dobutamine infusion rate well
. No patient
JACC Vol . 22, No . 2
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developed ventricular tachycardia (defined as three or more
consecutive ventricular premature complexes), hypotension
or dyspnea . I tt ,~ most common noncardiac side effects were
flushing (32%), headache (18%), tingling (7%), nausea (4%),
chills (3%) and tremors (3%) .
Discussion
The present study demonstrates that in patients with
coronary artery disease, dobutamine infusion can induce
regional wall motion abnormalities that can be detected by
cine MRI. The data also indicate the patient tolerance and
safety of this approach .
Importance of regional wall motion. Assessment of left
ventricular function is clinically important for the diagnosis
and management of patients with suspected ischemic heart
disease . It has been well established that stress-induced
impairment of regional left ventricular function is an early
and reliable sign of coronary artery stenosis (1-3) . In pa-
tients with known coronary artery disease, analysis of re-
gional left ventricular function plays a prominent role in
determining the therapeutic strategy, evaluating the efficacy
of the chosen therapy and assessing prognosis . A decrease in
global left ventricular ejection fraction frequently indicates
severe and extensive myocardial ischemia . However, in the
presence of less severe ischemia, compensatory hyperfunc-
tion in nonischemic myocardium may produce a normal
global ejection fraction that limits the potential of Lhe ejec-
tion fraction to detect regional ischemia (21,22) . Therefore,
analysis of regional wall motion would hate important
clinical value to assess the presence, site and severity of
coronary artery disease .
Diagnostic value of dobutamine stress magnetic resonance
imaging . Our results suggest that dobutamine stress with
cine MRI is feasible, safe and accurate for the diagnosis of
coronary artery disease . Stress-induced wall motion abnor-
malities were observed in 30 of 3" patients with angiograph-
ically proved coronary artery disease, yielding an overall
sensitivity of 81%, with a sensitivity of % for detecting
multivessel disease . The test yielded negative results in eight
of eight patients without coronary artery disease, resulting in
a specificity of 100%. The value of dobutamine in detecting
coronary artery disease has been assessed in studies using
electrocardiography (23), radionuclide ventriculography
(24), two-dimensional echocardiograpl y (16-20) and planar
(25) and tomographic (26) thallium myocardial perfusion
scintigraphy. Our data compare favorably with data in
previous reports on myocardial imaging techniques during
dobutamine stress . The high sensitivity in the present study
may be explained by the high spatial and improved temporal
resolution of the technique used . In addition, beta-
adrenergic blocking agents were discontinued a48 h before
the test in all patients, resulting in marked hemodynamic
changes during dobutamine infusion associated with a sub-
stantial increase in myocardial oxygen demand beyond sup-
ply. Sev°ral studies (17,27-29) have emphasized the impor-
JACC Vol. 22, No. 2
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tance of an increase in heart rate during dobutamine infusion
for provoking myocardial ischemia . The high sensitivity may
also be attributed by the maintenance of peak dobutamine
stress during image acquisition because stress-induced wall
motion abnormalities may resolve rapidly when the imposed
cardiovascular stress is terminated . The reported specificity
of 100% might have been affecter! by excluding patients with
valvular, congenital and cardiomyopathic heart disease .
Previous studies on pharmacologic stress magnetic reso-
nance imaging . Pharmacologic stress testing during MRI has
been reported using dipyridamole as a stress agent . In a
selected group of patients with severe coronary artery dis-
ease, l3aer et al . (13) performed dipyridamole infusion during
gradient echo MRI. The test result was considered positive
for coronary artery disease if wall motion abnormalities
occurred that were absent at rest . The investigators found a
sensitivity of 78% for detection of coronary artery disease .
In a more heterogeneous group of patients, Pennell et al . (30)
demonstrated an overall 62% sensitivity of dipyridamole
MRI for detecting coronary artery disease . Although these
initial results were promising, dipyridamole has several
drawbacks . It has a long duration of action associated with a
high incidence of side effects that often require rapid reversal
with aminophylline. Furthermore, the coronary vasodilating
effects are not consistent in a substantial number of patients
and generation of incremental cardiac stress resembling
exercise is not possible . Additionally, its main action is to
create a flow maldistribution without causing increased
myocardial oxygen demand (31) . Experimental studies (14)
demonstrated that dipyridamole was more effective than
dobutamine in inducing myocardial perfusion abnormalities,
whereas dobutamine was superior in causing wall motion
abnormalities . In this context, dipyridamole can be seen as a
perfusion marker and dobutamine as a functional marker .
Recently, Pennell et al . (32) were the first to report tine
MRI during dubutamine stress for the detection of coronary
artery disease by qualitative wall motion analysis . In their
group of patients with a high pretest likelihood of coronary
artery disease, dobutamine stress during cine MRI correctly
identified 20 (91%) of the 22 patients with significant coro-
nary artery disease. Although the dobutamine stress proto-
col was well tolerated, the investigators observed a high
incidence (%%) of chest discomfort .
Comparison with dobutamine stress echocardiographic
studies . Our results are in agreement with previous studies
using dobutamine stress during echocardiography. Cohen et
al . (17), using digital echocardiography during dobutamine
stress with doses up to 40 pg/kg per min, obtained a
sensitivity of 86% and a specificity of 95% for the detection
of coronary artery disease . In a similar study of 103 patients
examined at peak dobutamine infusion rates of 30 ,ug/kg per
min, Sawada et al . (18) reported a sensitivity and specificity
of 92% and 79%, respectively . In 141 patients, Marcovitz
and Armstrong (19) found a high sensitivity of 96% of
echocardiography during dobutamine stress (30 µg/kg per
min) for detecting patients with coronary artery disease .
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However, the reported specificity was only 66%, which was
attributed to the inclusion of patients with wall motion
abnormalities at rest not associated with coronary artery
disease . Mazeika et al. (20) studied 50 patients with sus-
pected coronary artery disease during dobutamine stress
(S20 pg/kg per min) and found an overall sensitivity of 78%
and specificity of 93% for the detection of coronary
artery
disease .
Comparison with dobutamine thallium-261 perfusion stud-
ies. Dobutamine was used in combinatior with planar
thallium-201 scintigraphy by Mason et al . (25), who showed
a sensitivity of 94% for detecting coronary artery disease .
Pennell et al . (26) studied 50 patients with coronary artery
disease and demonstrated that dobutamine thallium perfu-
sion tomography was a useful technique for detecting, local-
izing and assessing myocardial ischemia, particularly when
exercise potential is limited . They reported a sensitivity of
97% for detecting coronary artery disease .
Clinical value and advantages of dobutamine stress . Dob-
utamine stress approximates the hemodynamic alterations
during physical exercise by increasing heart rate, systolic
blood pressure and ventricular contractility . A practical
advantage of dobutamine, which can be easily administered
by a peripheral line, is its short plasma half-life of 2 min,
accounting for rapid onset and cessation of action . Conse-
quently, if side effects occur, they are short-lived and rarely
require reversal with a beta-blocking agent . The increase in
heart rate caused by dobutamine shortens imaging time,
thereby improving patient tolerance . For purposes of image
analysis, dobutamine-induced hyperkinesia in nonischemic
areas provides natural contrast with ischemic zones that
exhibit stress-induced wall motion abnormalities . The high
sensitivity of dobutamine stress in detecting coronary artery
disease, as demonstrated in our study and in studies com-
paring dobutamine stress echocardiography with studies
using dipyridamole as a stress agent (33). may account for
the increased application of dobutamine stress with imaging
techniques that rely on assessment of regional left ventricu-
lar function .
Adverse reactions to dobutamine. The present data indi-
cate that dobutamine infusion up to 20 µg/kg per min is well
tolerated and safe for diagnostic MRI . In all cases, the
adverse effects were mild to moderate in intensity and
short-lived. The occurrence of arrhythmias is of concern,
but the only major adverse event in our study was one
episode of accelerated idioventricular rhythm that required
premature termination of the infusion . The other arrhyth-
mias only lengthened the imaging time because of ECG
triggering difficulties, without considerably degrading the
image quality . This safety profile and tolerance is in agree-
ment with previous studies (15-20) . Dobutamine-induced
chest pain rapidly resolved by reducing the infusion rate in
nine patients . No patient demonstrated hypotension, dys-
pneaa or severe arrhythmias during dobutamine infusion
.
Limitations. Our study has several limitations
. 1) A se-
lection bias was introduced because the pretest likelihood of
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coronary artery disease in this group of patients was high .
Therefore, further studies are required to establish the
clinical value of dobutamine MR1 in a group of patients
referred for initial diagnostic stress testing
. 2) Pharmacologic
stress testing is not a physiologic mode to provoke ischemia .
However, among several alternative stress methods, dobu-
tamine infusion most appropriately reflects dynamic exer-
cise
. Hemodynamic variables such as heart rate and systolic
blood pressure are increased during dobutamine stress re-
sembling physical exercise . 3) For purposes of patient ac-
ceptability and duration of one examination, we obtained
cine MR
images only at baseline and during peak dobu-
tamine infusion . In addition, both the acquisition and anal-
ysis of cine MR images are time-consuming
. Moreover,
patients demonstrating claustrophobia during image acquisi-
tion are of concern. Therefore, the current approach limits
its introduction into clinical practice . However, recent ad-
vances in fast imaging sequences and computer-assisted
measurements are promising . In this respect, ultrafast MRI
during different levels of stress will be possible, thereby
mimicking the graded exercise stress test to detect an
ischemic threshold. 4) We obtained only six adjacent cardiac
MR images in the short-axis plane . The total examination
time within the magnet bote lasted approximately I h. For
reasons of ethics and patient acceptability, our imaging
protocol did not allow acquisition of images in the long-axis
plane of the heart. Accordingly, our study does not provide
a complete set of data on regional wall motion .
5) Only qualitative wall motion analysis was performed in
this study. In the future, quantitative wall motion analysis
should be assessed because both endocardial and epicardial
interfaces are well defined by cine MRI, allowing accurate
quantification of systolic wall thickening . A modification of
the centerline method, as described previously for echocar-
diography (34), may be a valuable tool for assessing regional
wall thickening on tine MRI . Currently, all studies reporting
on dobutamine stress are based solely on qualitative wall
motion analysis . In addition, future studies should address a
correlation of stress-induced wall motion asynergy with the
distribution of diseased coronary arteries . Also, difficulties
arising from cardiac translation and rotation are of concern,
but further development of myocardial tagging techniques
(35) and three-dimensional display (36) may circumvent
these problems in the near future .
Conclusions. Dobutamine stress MRI is a feasible, safe
and accurate technique for the noninvasive assessment of
functionally significant coronary artery disease . Dobutamine
infusion is a well tolerated and adequate alternative to
physical exercise for detecting myocardial ischemia as dem-
onstrated by stress-induced wall motion abnormalities
. Cine
MRI provide high quality images with three-dimensional
information without the need for radiation exposure and
contrast agents
. Further development of ultrafast MRI (37)
ill shorten imaging time, reduce motion artifacts, circum-
vent triggering difficulties arising from arrhythmias and
improve patient tolerance . In conjunction with still-
JACC Vol . 22 . No. 2
August 1993
:431-9
improving image quality, three-dimensional display and fur-
ther improvement of temporal resolution, this technique may
warrant its applicability to clinical cardiology .
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